戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 f neuroleptic associated cerebral oedema and neuroleptic malignant syndrome.
2 cal antipsychotics and resembles "classical" neuroleptic malignant syndrome.
3 ted them as high or low probability of being neuroleptic malignant syndrome.
4 signated as having high probability of being neuroleptic malignant syndrome.
5 xicities unrelated to (but misattributed as) neuroleptic malignant syndrome.
6 esponsible for most, if not all, features of neuroleptic malignant syndrome.
7 ntagonism, produces the clinical syndrome of neuroleptic malignant syndrome.
8 other end-organs that function abnormally in neuroleptic malignant syndrome.
9 syndrome and 13 cases of risperidone-induced neuroleptic malignant syndrome against three criteria se
10  They assessed 19 cases of clozapine-induced neuroleptic malignant syndrome and 13 cases of risperido
11    Nine of the 19 cases of clozapine-related neuroleptic malignant syndrome and eight of the 13 cases
12 s will be discussed: malignant hyperthermia, neuroleptic malignant syndrome, anticholinergic poisonin
13                                              Neuroleptic malignant syndrome can occur in patients giv
14 de effect profiles overlap considerably with neuroleptic malignant syndrome criteria, and atypical an
15 thors' goal was to analyze reported cases of neuroleptic malignant syndrome in patients given clozapi
16 gnosis, and treatment of serotonin syndrome, neuroleptic malignant syndrome, malignant hyperthermia,
17 ypotension, acute urinary retention, and the neuroleptic malignant syndrome or rhabdomyolysis.
18                                              Neuroleptic malignant syndrome should be treated by disc
19 eight of the 13 cases of risperidone-related neuroleptic malignant syndrome were designated as having
20               Published clinical findings on neuroleptic malignant syndrome were integrated with data
21 ess may constitute a trait vulnerability for neuroleptic malignant syndrome, which, when coupled with
22 as to develop a pathophysiological model for neuroleptic malignant syndrome with greater explanatory
23  Insufficient evidence exists for "atypical" neuroleptic malignant syndrome with novel antipsychotics

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。